Legal & General Group PLC Akero Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 55,562 shares of AKRO stock, worth $1.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,562

Previous 55,562 -0.0%

Holding current value

$1.73 Million

Previous $1.59 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.45 - $29.34 $23,616 - $32,303	-1,101 Reduced 1.94%	55,562 $1.59 Million
Q2 2024 Aug 14, 2024	BUY	$18.31 - $24.62 $123,336 - $165,840	6,736 Added 13.49%	56,663 $1.33 Million
Q1 2024 May 14, 2024	BUY	$17.76 - $31.18 $120,590 - $211,712	6,790 Added 15.74%	49,927 $1.26 Million
Q4 2023 Feb 15, 2024	SELL	$11.38 - $50.33 $1,274 - $5,636	-112 Reduced 0.26%	43,137 $1.01 Million
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $118,833 - $150,741	2,885 Added 7.15%	43,249 $2.19 Million
Q2 2023 Aug 14, 2023	BUY	$36.89 - $56.88 $404,941 - $624,371	10,977 Added 37.35%	40,364 $1.88 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $602,208 - $811,777	16,158 Added 122.14%	29,387 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$33.44 - $54.8 $100,085 - $164,016	2,993 Added 29.24%	13,229 $724,000
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $27,993 - $93,909	2,758 Added 36.88%	10,236 $349,000
Q2 2022 Aug 22, 2022	BUY	$8.0 - $15.01 $4,552 - $8,540	569 Added 8.24%	7,478 $71,000
Q4 2021 Feb 14, 2022	BUY	$19.87 - $26.24 $834 - $1,102	42 Added 0.61%	6,909 $146,000
Q3 2021 Nov 15, 2021	BUY	$18.65 - $25.46 $57,591 - $78,620	3,088 Added 81.71%	6,867 $153,000
Q2 2021 Aug 12, 2021	BUY	$24.81 - $32.35 $35,255 - $45,969	1,421 Added 60.26%	3,779 $93,000
Q1 2021 May 17, 2021	SELL	$24.04 - $34.19 $1,730 - $2,461	-72 Reduced 2.96%	2,358 $69,000
Q3 2020 Nov 13, 2020	BUY	$30.79 - $39.92 $18,042 - $23,393	586 Added 31.78%	2,430 $75,000
Q2 2020 Aug 14, 2020	BUY	$19.25 - $26.76 $10,857 - $15,092	564 Added 44.06%	1,844 $46,000
Q1 2020 May 14, 2020	BUY	$12.8 - $27.05 $4,736 - $10,008	370 Added 40.66%	1,280 $27,000
Q4 2019 Feb 13, 2020	BUY	$17.37 - $27.27 $2,622 - $4,117	151 Added 19.89%	910 $20,000
Q3 2019 Nov 13, 2019	BUY	$16.89 - $29.88 $12,819 - $22,678	759 New	759 $17,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.45B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Akero Therapeutics, Inc. Transaction History